Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...

Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

Here's the list of options activity happening in today's session: These itemized elaborations have been created using the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scilex Holding Company (SCLX – Research Report) ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.